HOME >> BIOLOGY >> NEWS
Hebrew University Ph.D. graduate wins young scientist prize in US

Dr. Qing Chen, a native of China who last year received her Ph.D. in medical science from the Hebrew University of Jerusalem, has been named one of the six winners of the Prize for Young Scientists, awarded annually by Amersham Biosciences and the journal Science. The prestigious prizes have been awarded annually since 1995 to outstanding Ph.D. graduates from around the world in the field of molecular biology.

The award to Dr.Chen was based on her research in the laboratory of Prof. Orna Amster-Choder at the Hebrew University-Hadassah Medical School on how cells process environmental information to generate appropriate adaptive responses.

Correct response to environmental stimuli, mediated by signal transduction systems, is the key to normal cell growth. Defects in sensing or in signaling lead to uncontrolled growth and tumor development. Through her studies with E coli bacteria, Dr. Chen succeeded in achieving a new understanding of how this sensing, signaling and response mechanism operates, furthering efforts to control the process of uncontrolled growth.

Dr. Chen was born in 1964 in Jinan, China, where she received her M.D. degree and a master's degree in biochemistry. She worked as a lecturer in the Department of Biochemistry at the Medical School of Beijing University for two years before coming to Jerusalem. Along with her Ph.D. degree awarded in 2002 by the Hebrew University, she received the Kennedy-Leigh Prize for outstanding Ph.D. research performed at the university as well as the Hebrew University Faculty of Medicine Prize for an excellent dissertation.

Prof. Amster-Choder commented that Dr. Chen expressed great love for Jerusalem during her stay at the Hebrew University.

Today, Dr. Chen studies the genomic features that make certain bacterial strains so dangerous as part of her work for the Walter Reed Army Institute of Research in Silver Spring, Md. Her goal is to some day help develop new vaccines for i
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-588-2904
The Hebrew University of Jerusalem
19-Nov-2003


Page: 1 2

Related biology news :

1. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
2. Defensive action by influenza viruses demonstrated by Hebrew university researcher
3. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
4. Scientists in Germany and Hebrew University illuminate process in control of flowering in plants
5. Hebrew University young researcher award goes to Dr. Nayef Jarrous
6. Hebrew University, German and British researchers develop means to help stress sufferers
7. Hebrew University researcher studies reorganization of brain in blind people
8. Hebrew University researchers develop method to improve neutraceutical absorption
9. Faster method for growing adult stem cells for bone regeneration developed at Hebrew University
10. Hebrew University researcher wins prize for work leading to new anti-cancer drugs
11. Hebrew University excavations strengthen dating of archaeological findings to David, Solomon

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hebrew University graduate wins young scientist prize

(Date:5/23/2013)... are billions of animal and plant specimens from birds, ... stacked, stored and preserved in jars and collection drawers. ... to understanding how the Earth,s biodiversity is changing in ... only the information were easily accessible. , A new ... a team from the University of Colorado Boulder, is ...
(Date:5/23/2013)... MADISON, Wis. In an age when microbial pathogens ... to tamp down infection, a team of Wisconsin scientists ... of curbing the bacteria that cause staph infections. , ... Chemical Society , a group led by University of ... interfere with the "quorum sensing" behavior of Staphylococcus ...
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4University of Wisconsin chemists find new compounds to curb staph infection 2Tests lead to doubling of fuel cell life 2
(Date:5/22/2013)... The Conference Forum announced ... Advance Clinical Trials conference taking place on September 19-20 ... , Disruptive thinkers from Novartis, Pfizer, Eli Lilly, ... approaches to reduce expensive infrastructure, engage patients and generate ... be big, or novel, or it must change the ...
(Date:5/22/2013)... 2013  Empire Genomics announced today it has ... novel genomic biomarker from Cornell University for use ... help in diagnosing and determining treatment for patients ... Neuroendocrine prostate cancer (NEPC) is a lethal variant ... novo, but more commonly arises after hormonal therapy ...
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company ... Microcap Conference, May 30, in New York, NY ... , CPA, Chief Financial Officer of Cleveland BioLabs, will present ... 1:30 p.m. Eastern Time.  A live and archived webcast of ... of the Cleveland BioLabs website at www.cbiolabs.com . ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2
Cached News: